Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Westlake Chemical Corporation (WLK)

  • Business News
  • Jan. 05, 2026, 16:49 UTC
  • 2
  • 1 comments

Westlake Strengthens Global Compounds Portfolio With Acquisition of ACI Compounding Solutions Business

Market reaction Comment Full text

ZEN Graphene Solutions Ltd (ZTEK)

  • Business News
  • Jan. 05, 2026, 16:17 UTC
  • 2
  • 1 comments

Zentek’s Albany Graphite Has Demonstrated Nuclear Grade Performance in Independent Testing, Opening Pathways Into a Range of Commercial Markets

Market reaction Comment Full text

Zealand Pharma A/S (company was delisted NASDAQ) (ZEAL)

  • Business News
  • Jan. 05, 2026, 16:05 UTC
  • 4
  • 1 comments

Zealand Pharma to present at the J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Incyte Corporation (INCY)

  • Business News
  • Jan. 05, 2026, 16:05 UTC
  • 7
  • 1 comments

Incyte anuncia resultados positivos del estudio pivotal de tafasitamab (Monjuvi®/Minjuvi®) en el tratamiento de primera línea del linfoma difuso de células B grandes

Market reaction Comment Full text

Inspira Technologies Oxy BHN (IINN)

  • Business News
  • Jan. 05, 2026, 15:46 UTC
  • 6
  • 1 comments

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Market reaction Comment Full text

Pfizer Inc (PFE)

  • Business News
  • Jan. 05, 2026, 15:01 UTC
  • 4
  • 1 comments

Pfizer Inc. - Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Market reaction Comment Full text

Pfizer Inc (PFE)

  • Business News
  • Jan. 05, 2026, 15:00 UTC
  • 6
  • 1 comments

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Market reaction Comment Full text

Cosmos Holdings Inc. (COSM)

  • Business News
  • Jan. 05, 2026, 14:30 UTC
  • 5
  • 1 comments

Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units

Market reaction Comment Full text

Inspira Technologies Oxy BHN (IINN)

  • Business News
  • Jan. 05, 2026, 14:30 UTC
  • 4
  • 1 comments

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Market reaction Comment Full text

Coherus BioSciences Inc (CHRS)

  • Business News
  • Jan. 05, 2026, 14:30 UTC
  • 5
  • 1 comments

Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)

Market reaction Comment Full text
  • Previous
  • 171
  • 172
  • 173
  • 174
  • 175
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189156)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124514)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin